MENU
OCGN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION
Ocugen (OCGN) Ownership - Who owns Ocugen?
Ocugen Inc company focused on discovering, developing, and commercializing novel gene and cell therapies and vaccines that improve health and offer hope for patients across the globe... Show more
Profile
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
278.28M
P/E Ratio
N/A
Total Cash
37.8M
Projected Growth
N/A
Total Debt
31.82M
Revenue
4.52M
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash/Share
0.13
Total Debt/Equity
N/A
Revenue/Share
0.02 USD as % of share price
Fundamentals
OCGN
Capitalization
278M
P/E Ratio
N/A
Risk (Beta)
2.21
Dividend Yield
N/A
Total Cash
37.8M
Total Cash/Share
0.13
Total Debt
31.8M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0.02%
Revenue
4.52M
ROE
N/A
Book Value
15.9M
P/B Ratio
17.48
Cash Flow
N/A
Earnings
-0.2
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
2.92M
Current Ratio
2.60
Current Revenue Per Employee
15589.47
Dividends Per Share - Security
N/A
EBITDA
-54.34M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-98.89
Shares Held By Institutions
91.1M
Shares Outstanding - Current
292M
Total Liabilities
48.5M
Total Volume MTD
N/A
Value
-1
Gain YTD
18.373
View a ticker or compare two or three
VS
VS
Show more...
Interact to see
Advertisement
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
a company, which engages in the development and commercialization of therapies for eye diseases
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
11 Great Valley Parkway
Phone
+1 484 328-4701
Employees
84
Web
https://www.ocugen.com